Osivax
PrivateLast Round
Grant
Aug 26, 2025
Total Funding Raised
$70.97M
Company Overview
Osivax is a biotechnology company that develops a transformative pipeline of universal vaccines designed to provide protection against viruses that mutate rapidly.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Advanced Materials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osivax Comparables
Compare Osivax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Centivax, Inc. | 87% | |
| hVIVO plc | 83% | |
| FluGen, Inc. | 81% | |
Osivax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 26, 2025 | ||||
| Series B | Mar 4, 2025 | ||||
| Grant | Dec 5, 2023 | ||||
| Grant | Jun 23, 2022 | ||||
| VC Round | Jul 8, 2020 | ||||
Grant | Jul 8, 2020 |
Key People
Founding team and executive leadership
Osivax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Noshaq | Series A |
| Anaxago | Series A |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| European Innovation Council Fund | Grant, VC Round |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2025
$19.5M grant from Public Health Emergency Medical Countermeasures Enterprise.
- Jul 6, 2025
Monthly visitors increased 267% MoM to 1.7K.
Osivax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Osivax's valuation, stock price, and market status.